Jared Holz, Mizuho Securities health care strategist, joins CNBC’s ‘Squawk on the Street’ to discuss weight loss drug makers, how CVS is boosting access to Wegovy, and more.
Mizuho’s Jared Holz: Novo Nordisk is trying to come up with strategies to regain market share
July 1, 2025
